+1 (619) 956-9114 info@myicfos.com
Follow us

iCFO Capital Global partnered with Titin KM Biomedical Corporation to raise $4M in seed funding.

February 14, 2024 by
iCFO Capital Global partnered with Titin KM Biomedical Corporation to raise $4M in seed funding.
Alejandra Rosas

LA JOLLA, CALIFORNIA - iCFO Capital Global, Inc., partnered with Titin KM Biomedical Corporation to raise $4M in growth funding for expanding from iCFO Capital Global investor network nationwide.

Titin KM Biomedical Corporation is a biomedical company in the final stages of bringing a revolutionary, shoulder assessment and rehabilitation device to market.

Titin KM Biomedical currently leases a manufacturing and office facility in Bozeman, Montana working towards GMP and ISO compliance. This facility houses a diverse range of manufacturing equipment that is utilized for a majority of the steps to successfully manufacture the Humero Tech C1. Titin KM has built an extensive and knowledgeable team that spans multiple professions to create both the disruptive product as well as the custom software. Titin KM has one granted patent as well as multiple national and international patents filed.

The Humero Tech C1, Titin KM Biomedical’s first product, is a revolutionary device that has the ability to change the current landscape of shoulder assessment and rehabilitation. This will be a Class II, 510k Exempt, Medical Device listed under product code ISD with the FDA. This device has features including real-time motion tracking, the ability to assess active range of motion and power output of the shoulder, and provide a constant omnidirectional resistance. Titin KM is nearing the delivery of beta test devices to Luminary Sites for testing and feedback from industry professionals regarding the device and improvements that can be implemented. We anticipate the Humero Tech C1 reaching the market in early 2024.

Company Accomplishments:

  • Successful research and development of the Humero Tech C1.
  • Successful manufacturing of a prototype Humero Tech C1.
  • The ability of the device to measure active range of motion, provide power output readings, and provide a constant, omnidirectional resistance.
  • A custom software which allows the status of each user to be tracked via objective data without subjective input.
  • Two grant applications being reviewed by the Department of Defense for funding opportunities.
  • Successfully built and integrated an elite team with years of experience.
  • A network of contacts including the NFL, MLB, NCAA, Physical Therapy, and Medical Academic Institutions.
  • Successful in-person demonstrations at industry specific exhibitions.
  • A brand of excellence and innovation.

Kole Mickolio is a radiology resident at Dartmouth-Hitchcock Medical Center. After overcoming a stroke in his twenties and multiple career-ending sports injuries in college, Kole developed a relentless passion for medical innovation across various industries. With a background in biomedical engineering, medicine, and kinesiology he has led Titin since its inception building each component of the team and product to where it now stands as one of the hottest-talked about commodities in shoulder orthopedic and rehabilitative spaces. 

For more information about the company visit: https://www.titinkmbiomedical.com/

iCFO Capital Global, Inc. provides a platform for Entrepreneurs to connect with our Private Investors that makes direct debt and equity investment for early-stage and expand growth businesses. To learn more about how your business can secure the funding it needs, visit: https://www.icfocapital.com/

Schedchule a meeting with our General Partner, Jock Cohen at the following link: https://calendly.com/icfo-jcohen